China SXT Pharmaceuticals, Inc. (SXTC) Financial Ratios Annual - Discounting Cash Flows
SXTC
China SXT Pharmaceuticals, Inc.
SXTC (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025
03-31
2024
03-31
2023
03-31
2022
03-31
2021
03-31
2020
03-31
2019
03-31
2018
03-31
2017
03-31
2016
03-31
Price Ratios
Price to Earnings Ratio -1.59 -45.76 -69.71 -47.91 -7.61 -72.26 -10.1 658.4 860.9 862.7 760.4
Price to Sales Ratio 1.22 86.83 112 144.2 16.78 41.57 20.12 144.5 145.7 209.5 28.94
Price to Book Ratio 0.228 9.79 15.5 19.35 2.66 12.44 11.05 91.24 311.2 551.9 144.9
Price to Free Cash Flow Ratio -0.967 -64.4 -111.6 -1,877 212.2 -140.9 196.9 -2,733 1,176 9,579 1,259
Price to Operating Cash Flow Ratio -2.77 -64.45 -112 -3,521 162.8 -150.8 111.2 4,237 532.5 3,489 589.8
Price Earnings to Growth Ratio 0.001 -0.354 0.83 0.571 -0.171 0.816 0.015 13.26 4,092 -79.2 0
EV to EBITDA 6.23 -51.54 -89.35 -50.53 -6.2 -100.1 -102.3 516.4 580.3 601.1 362.6
Liquidity Ratios
Current Ratio 4.37 3.54 1.6 1.35 1.31 1.25 1.6 2.47 1.4 1.37 1.03
Quick Ratio 4.24 3.4 1.51 1.31 1.25 1.2 1.53 2.31 1.11 1.09 0.723
Cash Ratio 3.55 3.01 1.36 1.2 0.907 0.718 0.594 1.44 0.128 0.018 0.002
Debt Ratio 0.046 0.045 0.114 0.127 0.061 0.001 0.31 0.159 0.05 0.056 0.076
Debt to Equity Ratio 0.059 0.064 0.19 0.256 0.125 0.003 0.715 0.251 0.117 0.163 0.645
Long Term Debt to Capitalization 0.004 0.006 0.008 0.008 0 0 0.004 0.004 0 0 0
Total Debt to Capitalization 0.056 0.06 0.16 0.204 0.111 0.003 0.417 0.2 0.105 0.14 0.392
Interest Coverage Ratio -4.24 -4.14 -4.62 -11.76 -141.4 -1.36 -0.4 342 2,095 39.67 4.1
Cash Flow to Debt Ratio -1.39 -2.38 -0.728 -0.021 0.131 -30.33 0.139 0.086 4.99 0.97 0.381
Margins
Gross Profit Margin 22.63% 21.11% 28.73% 21.62% 48.1% 59.43% 52.37% 65.77% 48.46% 47.36% 21.35%
Operating Profit Margin -178.1% -154% -130.4% -284.4% -199.4% -45.99% -25.98% 25.24% 23.25% 32.82% 5.62%
Pretax Profit Margin -218.9% -189.8% -160.7% -301% -207.8% -61.56% -201.3% 25.55% 23.19% 32.37% 5.08%
Net Profit Margin -218.9% -189.8% -160.7% -301% -220.4% -57.52% -199.3% 21.95% 16.92% 24.28% 3.81%
Operating Cash Flow Margin -125.7% -134.7% -99.98% -4.1% 10.31% -27.56% 18.1% 3.41% 27.36% 6% 4.91%
Free Cash Flow Margin -125.8% -134.8% -100.3% -7.68% 7.91% -29.5% 10.22% -5.29% 12.39% 2.19% 2.3%
Return
Return on Assets -11.01% -15.25% -13.4% -20.08% -17.1% -7.95% -47.4% 8.81% 15.51% 21.82% 2.25%
Return on Equity -17.55% -21.4% -22.24% -40.4% -34.92% -17.22% -109.4% 13.86% 36.14% 63.97% 19.06%
Return on Capital Employed -11.58% -17.13% -17.68% -37.24% -31.6% -13.76% -14.21% 15.87% 49.68% 86.48% 28.16%
Return on Invested Capital 64.76% 147.8% -55.8% -519.4% -186.8% -76.84% -15.03% 31.93% 38.29% 57.52% 12.96%
Turnover Ratios
Receivables Turnover Ratio 0.463 0.916 1.43 1.47 0.471 0.615 0.485 1.42 1.79 1.52 1.57
Payables Turnover Ratio 1.93 1.19 1.07 1.12 0.911 1.33 1.27 1.42 1.5 2.03 1.01
Inventory Turnover Ratio 1.37 1.66 1.7 2.91 1.33 2.25 2.75 2.38 2.86 2.52 1.7
Fixed Asset Turnover Ratio 4.39 4.9 3.42 1.55 1.64 2.67 2.71 3.88 4.71 10.06 8.65
Asset Turnover Ratio 0.05 0.08 0.083 0.067 0.078 0.138 0.238 0.401 0.917 0.899 0.591
Per Share Items ()
Revenue Per Share 0.543 4.31 2.22 7.39 62.57 166 417.5 681.8 591.1 411.1 2,975
Operating Cash Flow Per Share -0.682 -5.81 -2.22 -0.302 6.45 -45.74 75.56 23.26 161.7 24.68 146
Free Cash Flow Per Share -0.683 -5.81 -2.23 -0.567 4.95 -48.98 42.67 -36.07 73.22 8.99 68.38
Cash & Short Term Investments 8.67 45.15 13.92 65.06 373.3 463.2 589.4 887.9 47.18 5.52 9.15
Earnings Per Share -1.19 -8.18 -3.57 -22.23 -137.9 -95.48 -832.1 149.7 100 99.8 113.2
EBITDA Per Share -1.06 -6.43 -2.67 -20.07 -117.1 -64.33 -81.63 189.7 148.4 143.3 238.5
Dividend Per Share 0 0 0 0 0 0 0 0 0 0 0
Enterprise Value Per Share -6.63 331.5 238.1 1,014 725.9 6,438 8,354 97,933 86,085 86,120 86,474
Book Value Per Share 6.77 38.22 16.06 55.03 394.9 554.6 760.4 1,080 276.7 156 594.2
Price Per Share 1.54 374.2 249 1,065 1,050 6,900 8,400 98,550 86,100 86,100 86,100
Effective Tax Rate 0% 0% 0% 0% -6.07% 6.55% 0.979% 14.08% 27.04% 25% 25%
Short Term Coverage Ratio -1.7 -3.3 -0.84 -0.024 0.131 -35.47 0.14 0.087 4.99 0.97 0.381
Capital Expenditure Coverage Ratio -823.5 -1,159 -273 -1.14 4.29 -14.15 2.3 0.392 1.83 1.57 1.88
EBIT Per Revenue -1.78 -1.54 -1.3 -2.84 -1.99 -0.46 -0.26 0.252 0.233 0.328 0.056
EBITDA Per Revenue -1.49 -1.49 -1.2 -2.72 -1.87 -0.388 -0.196 0.278 0.251 0.349 0.08
Days of Sales Outstanding 788.6 398.4 254.8 248.9 775 593.4 752.8 256.8 203.5 239.7 231.8
Days of Inventory Outstanding 267.3 220.1 215 125.5 275 161.9 132.5 153.3 127.8 144.7 214.5
Days of Payables Outstanding 188.8 307.8 339.8 325.4 400.6 274.3 288.2 256.3 242.9 179.6 360.4
Cash Conversion Cycle 867.1 310.6 130.1 48.96 649.4 481 597.2 153.7 88.42 204.7 85.89
Cash Conversion Ratio 0.574 0.71 0.622 0.014 -0.047 0.479 -0.091 0.155 1.62 0.247 1.29
Free Cash Flow to Earnings 0.575 0.711 0.625 0.026 -0.036 0.513 -0.051 -0.241 0.732 0.09 0.604
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program